GLOBE LIFE INC. (GL)
SIC breadcrumb: Finance, Insurance, And Real Estate > Insurance Carriers > SIC 6311 Life Insurance
SEC company page: https://www.sec.gov/edgar/browse/?CIK=320335. Latest filing source: 0000320335-26-000090.
Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.
At a glance
- Revenue
- 5,994,318,000 USD verified
- Net income
- 1,161,238,000 USD verified
- Assets
- 30,813,692,000 USD verified
- Free cash flow
- 1,253,907,000 USD computed
- Net margin
- 19.37% computed
- Revenue YoY
- +3.74% computed
- ROE
- 19.44% computed
Peer & cluster context
Peer comparisons including GL
- Life insurers: peer review · market-risk page
Peer percentile fingerprint
Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 6311 Life Insurance, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.
Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
|---|---|---|---|---|
| Revenue | 5,994,318,000 | USD | 2025 | 2026-02-25 |
| Net income | 1,161,238,000 | USD | 2025 | 2026-02-25 |
| Assets | 30,813,692,000 | USD | 2025 | 2026-02-25 |
Financials
Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-25. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000320335.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,934,629,000 | 4,155,573,000 | 4,303,751,000 | 4,527,532,000 | 4,737,921,000 | 5,112,038,000 | 5,226,740,000 | 5,447,533,000 | 5,778,069,000 | 5,994,318,000 |
| Net income | 549,779,000 | 1,454,494,000 | 701,466,000 | 760,790,000 | 731,773,000 | 1,031,114,000 | 894,386,000 | 970,755,000 | 1,070,762,000 | 1,161,238,000 |
| Diluted EPS | 4.49 | 12.22 | 6.09 | 6.83 | 6.82 | 9.99 | 9.04 | 10.07 | 11.94 | 14.07 |
| Operating cash flow | 1,398,708,000 | 1,429,058,000 | 1,277,647,000 | 1,363,874,000 | 1,476,434,000 | 1,437,680,000 | 1,422,194,000 | 1,482,425,000 | 1,402,440,000 | 1,396,391,000 |
| Capital expenditures | 25,162,000 | 20,285,000 | 45,092,000 | 42,203,000 | 41,756,000 | 38,244,000 | 27,929,000 | 49,553,000 | 71,045,000 | 142,484,000 |
| Dividends paid | 66,931,000 | 68,831,000 | 71,421,000 | 74,188,000 | 78,192,000 | 80,043,000 | 80,547,000 | 84,116,000 | 85,485,000 | 86,067,000 |
| Share buybacks | 404,784,000 | 412,989,000 | 421,749,000 | 459,569,000 | 443,866,000 | 541,435,000 | 454,638,000 | 511,100,000 | 1,002,109,000 | 880,983,000 |
| Assets | 21,436,087,000 | 23,474,985,000 | 23,095,722,000 | 25,977,460,000 | 29,046,731,000 | 29,768,048,000 | 25,986,797,000 | 28,051,499,000 | 29,076,181,000 | 30,813,692,000 |
| Liabilities | 16,869,226,000 | 17,243,564,000 | 17,680,545,000 | 18,683,153,000 | 20,275,639,000 | 21,125,242,000 | 22,037,220,000 | 23,564,696,000 | 23,770,661,000 | 24,839,113,000 |
| Stockholders' equity | 4,566,861,000 | 6,231,421,000 | 5,415,177,000 | 7,294,307,000 | 933,521,000 | 2,003,808,000 | 3,949,577,000 | 4,486,803,000 | 5,305,520,000 | 5,974,579,000 |
| Free cash flow | 1,373,546,000 | 1,408,773,000 | 1,232,555,000 | 1,321,671,000 | 1,434,678,000 | 1,399,436,000 | 1,394,265,000 | 1,432,872,000 | 1,331,395,000 | 1,253,907,000 |
Ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | 13.97% | 35.00% | 16.30% | 16.80% | 15.45% | 20.17% | 17.11% | 17.82% | 18.53% | 19.37% |
| Return on equity | 12.04% | 23.34% | 12.95% | 10.43% | 78.39% | 51.46% | 22.65% | 21.64% | 20.18% | 19.44% |
| Return on assets | 2.56% | 6.20% | 3.04% | 2.93% | 2.52% | 3.46% | 3.44% | 3.46% | 3.68% | 3.77% |
| Liabilities / equity | 3.69 | 2.77 | 3.26 | 2.56 | 21.72 | 10.54 | 5.58 | 5.25 | 4.48 | 4.16 |
Industry Peer Context
Net margin peer context
ROE peer context
ROA peer context
Financial Bridges
Free cash flow = operating cash flow - capital expenditures
Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0000320335-26-000090; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0000320335-26-000090; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0000320335-26-000090; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Financial Charts
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: Revenues. Source concepts: us-gaap:Revenues.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: PaymentsOfDividends. Source concepts: us-gaap:PaymentsOfDividends.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: Assets. Source concepts: us-gaap:Assets.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: Liabilities. Source concepts: us-gaap:Liabilities.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.
Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0000320335-26-000090; filed 2026-02-25. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
As-reported value updates
Quarterly
Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-05. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000320335.json.
| Quarter | End Date | Revenue | Net Income | Diluted EPS | Method |
|---|---|---|---|---|---|
| 2022-Q3 | 2022-09-30 | 1.90 | reported discrete quarter | ||
| 2023-Q1 | 2023-03-31 | 2.28 | reported discrete quarter | ||
| 2023-Q2 | 2023-06-30 | 2.24 | reported discrete quarter | ||
| 2023-Q3 | 2023-09-30 | 1,384,118,000 | 257,083,000 | 2.68 | reported discrete quarter |
| 2023-Q4 | 2023-12-31 | 1,415,691,000 | 274,802,000 | derived Q4 = FY annual - nine-month YTD | |
| 2024-Q1 | 2024-03-31 | 1,416,139,000 | 254,217,000 | 2.67 | reported discrete quarter |
| 2024-Q2 | 2024-06-30 | 1,440,246,000 | 258,355,000 | 2.83 | reported discrete quarter |
| 2024-Q3 | 2024-09-30 | 1,455,407,000 | 302,994,000 | 3.44 | reported discrete quarter |
| 2024-Q4 | 2024-12-31 | 1,466,277,000 | 255,196,000 | derived Q4 = FY annual - nine-month YTD | |
| 2025-Q1 | 2025-03-31 | 1,480,422,000 | 254,563,000 | 3.01 | reported discrete quarter |
| 2025-Q2 | 2025-06-30 | 1,481,287,000 | 252,749,000 | 3.05 | reported discrete quarter |
| 2025-Q3 | 2025-09-30 | 1,512,988,000 | 387,843,000 | 4.73 | reported discrete quarter |
| 2025-Q4 | 2025-12-31 | 1,519,621,000 | 266,083,000 | derived Q4 = FY annual - nine-month YTD | |
| 2026-Q1 | 2026-03-31 | 1,559,619,000 | 270,526,000 | 3.39 | reported discrete quarter |
| 2026-Q2 | 2026-06-30 | 1,599,730,000 | 287,747,000 | 3.65 | reported discrete quarter |
Quarterly Charts
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0000320335-26-000216; filed 2026-08-05. Concept: Revenues. Source concepts: us-gaap:Revenues.
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0000320335-26-000216; filed 2026-08-05. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.
Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0000320335-26-000216; filed 2026-08-05. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.
Business
Read GL's verbatim Item 1 Business section from its latest 10-K: Business.
Risk Factors
Read GL's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.
Latest quarter (10-Q)
Latest 10-Q source: 0000320335-26-000216.
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with Globe Life's Condensed Consolidated Financial Statements and Notes thereto appearing elsewhere in this report. The following management discussion will only include comparison to prior year.
"Globe Life" and the "Company" refer to Globe Life Inc. and its subsidiaries and affiliates.
Results of Operations
| How Globe Life Views Its Operations. Globe Life Inc. is the holding company for a group of insurance companies that market through exclusive, direct-to-consumer and independent distribution channels primarily individual life and supplemental health insurance to lower middle to middle-income households throughout the United States. We view our operations by segments, which are the insurance product lines of life and supplemental health, and the investment segment that supports the product lines. | |
|---|---|
| Insurance Product Line Segments. The insurance product line segments involve the marketing, underwriting, and administration of policies. Each product line is further subdivided by the various distribution channels that market the insurance policies. Each distribution channel operates in a niche market offering insurance products designed for that particular market. Whether analyzing profitability of a segment as a whole, or the individual distribution channels within the segment, the measure of profitability used by management is the underwriting margin, as seen below: | |
| Premium revenue (Policy obligations) (Policy acquisition costs and commissions) Underwriting margin | |
| Investment Segment. The investment segment involves the management of our capital resources, including investments and the management of liquidity. Our measure of profitability for the investment segment is excess investment income, as seen below: | |
| Net investment income(Required interest on policy liabilities) Excess investment income |
60
GL Q2 2026 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Globe Life serves the lower-middle to middle-income market. We believe this market is underserved, has significant growth potential, and provides us with a distinct competitive advantage. This advantage is protected due not only to our ability to efficiently reach this market through both exclusive and direct to consumer distribution channels, but also due to the amount of data and experience we possess, as we have been in this same market for over 60 years with essentially the same products. The basic protection life and health insurance products we offer are specifically designed to help provide financial security to consumers in this market.
Current Highlights.
•On a diluted basis, net income per common share increased 16% from $6.07 to $7.04 and net operating income per common share increased from $6.34 to $7.04, an 11% increase as of June 30, 2026 and 2025, respectively.
•Net income as a return on equity (ROE) for the six months ended June 30, 2026 was 18.4% and net operating income as an ROE, excluding accumulated other comprehensive income(1), was 14.3%.
•Total premium increased 6% over the same period in the prior year. Life premium increased 3% for the period from $1.67 billion in 2025 to $1.71 billion in 2026. Health premium increased 14% to $854 million from $748 million over the prior-year period.
•Total net sales increased 10% over the same period in the prior year from $439 million in 2025 to $484 million in 2026. Average producing agent count increased by 9% at both Liberty National and Family Heritage Divisions. However, total average producing agent count across all of the exclusive agencies decreased over the prior year primarily related to a decrease in the American Income Division.
•Book value per share increased 18% over the same period in the prior year from $66.07 to $78.18. Book value per share, excluding accumulated other comprehensive income(1), increased 11% over the prior year from $90.26 in 2025 to $100.04 in 2026.
•For the six months ended June 30, 2026, the Company repurchased 2.6 million shares of Globe Life Inc. common stock at a total cost of $378 million for an average share price of $146.99.
The following graphs represent net income and net operating income(1) for the six month periods ended June 30, 2026 and 2025.
(1)As shown in the charts above, net operating income is primarily comprised of insurance underwriting margin plus excess investment income and annuity and other income, offset by operating expenses after tax and, as such, is considered a non-GAAP measure. It has been used consistently by Globe Life's management for many years to evaluate the operating performance of the Company. Net operating income differs from net income primarily because it excludes certain non-operating items such as realized gains and losses and certain significant and unusual items included in net income. Net income is the most directly comparable GAAP measure.
Net operating income as an ROE, excluding AOCI, is considered a non-GAAP measure. Management utilizes this measure to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(1.7) billion and $(2.0) billion for the six months ended June 30, 2026 and 2025, respectively.
Book value per share, excluding AOCI, is also considered a non-GAAP measure. Management utilizes this measure to view the book value of the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(21.86) and $(24.19) per share for the six months ended June 30, 2026 and 2025, respectively.
Refer to Analysis of Profitability by Segment for non-GAAP reconciliation to GAAP.
61
GL Q2 2026 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Summary of Operations.
•Net income totaled $558 million during the six months ended June 30, 2026, compared with $507 million, in the same period in 2025, an increase of 10%.
•On a diluted basis, net income per common share for the six months ended June 30, 2026 increased 16% from $6.07 to $7.04.
•Net operating income was $558 million for the six months ended June 30, 2026, compared with $530 million for the same period in 2025, an increase of 5%.
•On a diluted basis, net operating income per common share for the six months ended June 30, 2026 increased from $6.34 to $7.04, an 11% increase.
Net operating income is primarily comprised of insurance underwriting margin plus excess investment income and annuity and other income, offset by operating expenses, after tax and, as such, is considered a non-GAAP measure. Net income is the most directly comparable GAAP measure. We do not consider realized gains and losses to be a component of our core insurance operations or operating segments. Additionally, net income is affected by certain non-operating items. We do not view these items as components of core operating results because they are not indicative of past performance or future prospects of the insurance operations. We remove items such as these that relate to prior periods or are non-operating items when evaluating the results of current operations, and therefore exclude such items from our segment analysis for current periods.
The Company's core operations remain strong, including sales and premium growth, and we continue to achieve an operating ROE (excluding accumulated other comprehensive income) generally in the mid-teens.
62
GL Q2 2026 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Globe Life's operations on a segment-by-segment basis are discussed in depth below. Net operating income has been used consistently by management for many years to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. It differs from GAAP net income primarily because it excludes certain non-operating items such as realized gains and losses and other significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.
Analysis of Profitability by Segment
(Dollar amounts in thousands)
| Six Months Ended June 30, | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2025 | Change | % | ||||||||||
| Life insurance underwriting margin | $ | 708,408 | $ | 677,338 | $ | 31,070 | 5 | ||||||
| Health insurance underwriting margin | 193,789 | 182,778 | 11,011 | 6 | |||||||||
| Excess investment income | 74,969 | 70,698 | 4,271 | 6 | |||||||||
| Segment profit or (loss) | 977,166 | 930,814 | 46,352 | 5 | |||||||||
| Annuity and other income | 6,229 | 3,971 | 2,258 | 57 | |||||||||
| Administrative expense | (185,732) | (173,596) | (12,136) | 7 | |||||||||
| Other corporate expense | (108,729) | (102,544) | (6,185) | 6 | |||||||||
| Pre-tax total | 688,934 | 658,645 | 30,289 | 5 | |||||||||
| Applicable taxes | (130,729) | (128,213) | (2,516) | 2 | |||||||||
| Net operating income | 558,205 | 530,432 | 27,773 | 5 | |||||||||
| Reconciling items, net of tax: | |||||||||||||
| Realized gains (losses) | 4,472 | (14,607) | 19,079 | ||||||||||
| Other expenses | (72) | — | (72) | ||||||||||
| Legal proceedings | (4,332) | (8,513) | 4,181 | ||||||||||
| Net income | $ | 558,273 | $ | 507,312 | $ | 50,961 | 10 |
The life insurance segment is our primary segment and is the largest contributor to earnings in each period presented. The life insurance segment underwriting margin increased $31 million compared with the prior period, driven by premium growth and lower policy obligations as a percent of premium. Excess investment income increased $4 million compared with the prior period, primarily due to higher yields on fixed maturities, commercial mortgage loans and other long-term investments. The health segment experienced favorable underwriting margin as a result of higher premiums from strong growth in Medicare Supplement sales in addition to the positive impact of higher premium rates on individual Medicare Supplement policies as a result of approved rate increases.
63
GL Q2 2026 FORM 10-Q
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
In 2026, the largest contributor of total underwriting margin was the life insurance segment and the primary distribution channel was American Income. The following charts represent the breakdown of total underwriting margin by operating segment and distribution channel for the six months ended June 30, 2026.
Total premium income rose 6% for the six months ended June 30, 2026 to $2.6 billion. Total net sales increased 10% to $484 million when compared with 2025. Total first-year collected premium (defined in the following section) increased 19% to $408 million for 2026, compared to $343 million in 2025.
Life insurance premium income increased 3% to $1.71 billion compared to $1.67 billion in the prior-year period. Life net sales increased 1% to $307 million for the six months ended June 30, 2026 as compared to the year-ago period. First-year collected life premium increased 2% to $234 million. Life underwriting margin, as a percent of premium, was flat at 41% for 2026. Underwriting margin increased to $708 million in 2026, compared to $677 million in 2025.
Health insurance premium income increased 14% to $854 million compared to $748 million in the prior-year period. Health net sales rose 30% to $177 million for the six months ended June 30, 2026. First-year collected health
[Excerpt truncated for page length; source filing is linked above.]
Latest 10-K MD&A (excerpt)
Latest 10-K Item 7 source: 0000320335-26-000090. The complete FY 2025 MD&A is published at /company/GL/mda/fy2025/.
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with Globe Life's Consolidated Financial Statements and Notes thereto appearing elsewhere in this report. The following management discussion will only include comparison to prior year. For discussion regarding activity from 2023, please refer to the prior filed Form 10-Ks at www.sec.gov.
"Globe Life" and the "Company" refer to Globe Life Inc. and its subsidiaries and affiliates.
Results of Operations
| How Globe Life Views Its Operations. Globe Life Inc. is the holding company for a group of insurance companies that market through exclusive, direct-to-consumer and independent distribution channels primarily individual life and supplemental health insurance to lower middle to middle-income households throughout the United States. We view our operations by segments, which are the insurance product lines of life and supplemental health, and the investment segment that supports the product lines. | |
|---|---|
| Insurance Product Line Segments. The insurance product line segments involve the marketing, underwriting, and administration of policies. Each product line is further subdivided by the various distribution channels that market the insurance policies. Each distribution channel operates in a niche market offering insurance products designed for that particular market. Whether analyzing profitability of a segment as a whole, or the individual distribution channels within the segment, the measure of profitability used by management is the underwriting margin, as seen below: | |
| Premium revenue (Policy obligations) (Policy acquisition costs and commissions) Underwriting margin | |
| Investment Segment. The investment segment involves the management of our capital resources, including investments and the management of liquidity. Our measure of profitability for the investment segment is excess investment income, as seen below: | |
| Net investment income(Required interest on policy liabilities) Excess investment income |
21
GL 2025 FORM 10-K
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Globe Life serves the lower-middle to middle-income market. We believe this market is underserved, has significant growth potential, and provides us with a distinct competitive advantage. This advantage is protected due not only to our ability to efficiently reach this market through both exclusive and direct to consumer distribution channels, but also due to the amount of data and experience we possess, as we have been in this same market for over 60 years with essentially the same products. The basic protection life and health insurance products we offer are specifically designed to help provide financial security to consumers in this market.
Current Highlights.
•Net income as a return on equity (ROE) for the year ended December 31, 2025 was 20.9% and net operating income as an ROE, excluding accumulated other comprehensive income(1) was 16.0%.
•Total premium increased 5% over the same period in the prior year. Life premium increased 3% for the period from $3.3 billion in 2024 to $3.4 billion in 2025. Health premium increased 9% to $1.5 billion over the prior-year period of $1.4 billion.
•Total net sales increased 13% over the same period in the prior year from $840 million in 2024 to $948 million in 2025. The average producing agent count across all of the exclusive agencies increased 3% over the prior year.
•Book value per share increased 19% over the same period in the prior year from $62.50 to $74.17. Book value per share, excluding accumulated other comprehensive income(1), increased 11% over the prior year from $86.40 in 2024 to $96.16 in 2025.
•For the year ended December 31, 2025, the Company repurchased 5.4 million shares of Globe Life Inc. common stock at a total cost of $685 million for an average share price of $126.41.
The following graphs represent net income and net operating income(1) for the twelve month periods ended December 31, 2025 and 2024.
(1)As shown in the charts above, net operating income is primarily comprised of insurance underwriting margin plus excess investment income and annuity and other income, offset by operating expenses after tax and, as such, is considered a non-GAAP measure. It has been used consistently by Globe Life's management for many years to evaluate the operating performance of the Company. It differs from net income primarily because it excludes certain non-operating items such as realized gains and losses and certain significant and unusual items included in net income. Net income is the most directly comparable GAAP measure.
Net operating income as an ROE, excluding accumulated other comprehensive income ("AOCI"), is considered a non-GAAP measure. Management utilizes this measure to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(1.8) billion and $(2.0) billion for the year ended December 31, 2025 and 2024, respectively.
Book value per share, excluding AOCI, is also considered a non-GAAP measure. Management utilizes this measure to view the book value of the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. The impact of the adjustment to exclude AOCI is $(21.99) and $(23.90) per share for the year ended December 31, 2025 and 2024, respectively.
Refer to Analysis of Profitability by Segment for non-GAAP reconciliation to GAAP.
22
GL 2025 FORM 10-K
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Summary of Operations.
•Net income totaled $1.16 billion in 2025, compared with $1.07 billion in 2024 and $971 million in 2023.
•On a diluted per common share basis, net income per common share for 2025 increased 18% to $14.07. Net income per common share, on a diluted per common share basis was $11.94 in 2024 and $10.07 in 2023.
•Net operating income was $1.20 billion in 2025, compared with $1.11 billion in 2024 and $1.03 billion in 2023.
•On a diluted per common share basis, net operating income per common share for 2025 increased 17% to $14.52. Net operating income per common share, on a diluted per common share basis, was $12.37 in 2024 and $10.65 in 2023.
Net remeasurement gains of $134.3 million in 2025, $46.3 million in 2024, and $3.2 million in 2023 were attributable to the Company's annual third-quarter review and unlocking of life and health long-term assumptions, including lapses, mortality and morbidity. See the remeasurement gain/loss table in Note 6—Policy Liabilities for additional information.
Overall, the Company continues to see positive signs in its core operations, including sales and premium growth, and continues to achieve an operating ROE (excluding accumulated other comprehensive income) generally in the mid-teens.
Net operating income is primarily comprised of insurance underwriting margin plus excess investment income and annuity and other income, offset by operating expenses, after tax and, as such, is considered a non-GAAP measure. Net income is the most directly comparable GAAP measure. We do not consider realized gains and losses to be a component of our core insurance operations or operating segments. Additionally, net income is affected by certain non-operating items. We do not view these items as components of core operating results because they are not indicative of past performance or future prospects of the insurance operations. We remove items such as these that relate to prior periods or are non-operating items when evaluating the results of current operations, and therefore exclude such items from our segment analysis for current periods.
23
GL 2025 FORM 10-K
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
Globe Life's operations on a segment-by-segment basis are discussed in depth below. Net operating income has been used consistently by management for many years to evaluate the operating performance of the Company and is a measure commonly used in the life insurance industry. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business.
Analysis of Profitability by Segment
(Dollar amounts in thousands)
| 2025 | 2024 | 2023 | 2025 Change | % | 2024 Change | % | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life insurance underwriting margin | $ | 1,509,361 | $ | 1,352,597 | $ | 1,192,972 | $ | 156,764 | 12 | $ | 159,625 | 13 | ||||||||||||
| Health insurance underwriting margin | 390,128 | 372,423 | 377,937 | 17,705 | 5 | (5,514) | (1) | |||||||||||||||||
| Excess investment income | 138,393 | 164,404 | 130,382 | (26,011) | (16) | 34,022 | 26 | |||||||||||||||||
| Segment profit or (loss) | 2,037,882 | 1,889,424 | 1,701,291 | 148,458 | 8 | 188,133 | 11 | |||||||||||||||||
| Annuity and other income | 9,470 | 7,636 | 8,800 | 1,834 | 24 | (1,164) | (13) | |||||||||||||||||
| Administrative expense | (355,595) | (342,430) | (301,161) | (13,165) | 4 | (41,269) | 14 | |||||||||||||||||
| Other corporate expense | (208,758) | (179,610) | (143,918) | (29,148) | 16 | (35,692) | 25 | |||||||||||||||||
| Pre-tax total | 1,482,999 | 1,375,020 | 1,265,012 | 107,979 | 8 | 110,008 | 9 | |||||||||||||||||
| Applicable taxes | (284,612) | (266,036) | (238,368) | (18,576) | 7 | (27,668) | 12 | |||||||||||||||||
| Net operating income | 1,198,387 | 1,108,984 | 1,026,644 | 89,403 | 8 | 82,340 | 8 | |||||||||||||||||
| Reconciling items, net of tax: | ||||||||||||||||||||||||
| Realized gains (losses) | (21,952) | (19,108) | (51,884) | (2,844) | 32,776 | |||||||||||||||||||
| Other expenses | (1,725) | (2,070) | (3,294) | 345 | 1,224 | |||||||||||||||||||
| Legal proceedings | (13,472) | (17,044) | (711) | 3,572 | (16,333) | |||||||||||||||||||
| Net income | $ | 1,161,238 | $ | 1,070,762 | $ | 970,755 | $ | 90,476 | 8 | $ | 100,007 | 10 |
The life insurance segment is our primary segment and is the largest contributor to earnings in each year presented. In 2025, the life insurance segment underwriting margin increased $157 million, compared with 2024. This was primarily a result of increased premiums and favorable policy obligations as a percent of premium due to a remeasurement gain resulting from the assumption updates in 2025. In 2024, the life insurance segment underwriting margin increased $160 million when compared with 2023. This was primarily a result of increased premiums and favorable policy obligations as a percent of premium in addition to a remeasurement gain as a result of assumption changes in 2024. Excess investment income decreased $26 million in 2025 compared with 2024, resulting from lower average invested asset growth and lower average earned yields on our short-term, direct commercial mortgage loan and limited partnership investments. In 2025, underwriting margin in the health segment increased to $390 million due to increased sales and rate increases in our Medicare supplement business, compared with $372 million in 2024 and $378 million in 2023.
24
GL 2025 FORM 10-K
Table of Contents
GLOBE LIFE INC.
Management's Discussion & Analysis
In 2025, the largest contributor of total underwriting margin was the life insurance segment and the primary distribution channel was the American Income Life Division (American Income). The following charts represent the breakdown of total underwriting margin by operating segment and distribution channel for the year ended December 31, 2025.
Total premium inc
[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]
MD&A history
Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.